This week, I had the privilege of attending a lecture held by Dr. Newman, where we focused on inflammatory breast cancer (IBC). It was a comprehensive session that provided new insights into the pathophysiology, diagnosis, and treatment of this aggressive form of breast cancer. What stood out to me was the emphasis on personalized treatment plans for IBC patients. The lecture explored the role of neoadjuvant therapy—chemotherapy or hormone therapy given before surgery—to shrink the tumor and improve surgical outcomes.
We also talked about the history of self assessment of breast cancer in the lecture. While BSEs were initially promoted as a key tool for early detection, the scientific community has since debated their effectiveness. This led to discussions about the limitations of self-assessment and how medical advancements, such as mammography and ultrasound imaging, have taken a more prominent role in breast cancer detection over the years.
No comments:
Post a Comment